journal article·2025-04Open access

Enhanced Tumor Ablation and Immune Activation Via Irreversible Electroporation and Functionalized Vermiculite Nanosheets

Runtan Li, Gaoli Niu, Yaoguang She, Ruiyan Li, Mengyu Yuan, Zhengcun Pei, Yong Kang, Xiaoyuan Ji

Small· Volume 21· Issue 17

Abstract

Abstract Irreversible electroporation (IRE) is a minimally invasive, non‐thermal tumor ablation technique that induces nanoscale membrane perforation, leading to immunogenic cell death (ICD). However, IRE alone is limited by uneven electric field attenuation, incomplete tumor ablation, and the immunosuppressive nature of the tumor microenvironment. To address these challenges, a multifunctional nanomaterial, vermiculite nanosheets/calcium peroxide nanosheets (VMT/CaO2 NSs), is developed to enhance the efficacy of IRE. VMT/CaO2 NSs exhibit a high specific surface area, intrinsic catalytic properties, and strong adsorption capacity, enabling them to adsorb antigens and damage‐associated molecular patterns released during IRE. This transforms the tumor site into an in situ tumor vaccine, promoting dendritic cell (DC) activation and enhancing antigen presentation. The catalytic activity of VMT/CaO2 NSs generates reactive oxygen species through Fenton‐like reactions, amplifying oxidative stress to eliminate residual tumor cells and modulate the dense extracellular matrix of the TME, improving immune cell infiltration. In vitro and in vivo studies demonstrate that the combination of VMT/CaO2 NSs with IRE significantly enhances tumor ablation, immune activation, and systemic antitumor immunity. The treatment effectively induces ICD, activates cytotoxic T lymphocytes (CD8⁺ T cells), and generates memory T cells, ensuring durable immune surveillance and reducing the likelihood of recurrence.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Microbial Inactivation Methods · Plasma Applications and Diagnostics · CAR-T cell therapy research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Advanced Medical Materials and Devices Medical College Tianjin University Tianjin 300072 China

Department of Gynecologic Oncology The First Affiliated Hospital of Henan Polytechnic University Jiaozuo 454000 China

Department of General Surgery First Medical Center Chinese PLA General Hospital Beijing 100853 China

Medical College Linyi University Linyi 276000 China

Funding

National Natural Science Foundation of China · China Postdoctoral Science Foundation

References (44)

Show source-provided references
1. 10.1148/radiol.202019219010.1148/radiol.2020192190 ↗
2. 10.1109/TBME.2014.236754310.1109/TBME.2014.2367543 ↗
3. 10.1200/JCO.2010.33.090210.1200/JCO.2010.33.0902 ↗
4. 10.1016/j.bioelechem.2020.10757010.1016/j.bioelechem.2020.107570 ↗
5. 10.1200/JCO.2012.44.973610.1200/JCO.2012.44.9736 ↗
6. 10.1148/radiol.201515116610.1148/radiol.2015151166 ↗
7. 10.1148/radiol.201716156110.1148/radiol.2017161561 ↗
8. 10.1016/j.nantod.2024.10221210.1016/j.nantod.2024.102212 ↗
9. 10.1093/annonc/mdw16810.1093/annonc/mdw168 ↗
10. 10.3389/fimmu.2018.0039810.3389/fimmu.2018.00398 ↗
11. 10.1073/pnas.08162689810.1073/pnas.081626898 ↗
12. 10.1148/radiol.1414031110.1148/radiol.14140311 ↗
13. 10.1245/s10434-012-2736-110.1245/s10434-012-2736-1 ↗
14. 10.1002/smll.20220031610.1002/smll.202200316 ↗
15. 10.1038/s41467-022-35215-310.1038/s41467-022-35215-3 ↗
16. 10.1021/acsnano.3c0500910.1021/acsnano.3c05009 ↗
17. 10.1002/advs.20210524010.1002/advs.202105240 ↗
18. 10.1126/sciadv.abb522310.1126/sciadv.abb5223 ↗
19. 10.1186/s12951-022-01682-510.1186/s12951-022-01682-5 ↗
20. 10.1016/j.bioactmat.2020.08.00510.1016/j.bioactmat.2020.08.005 ↗
21. 10.1002/advs.20180215710.1002/advs.201802157 ↗
22. 10.1002/adma.20180247910.1002/adma.201802479 ↗
23. 10.1038/s41467-021-21436-510.1038/s41467-021-21436-5 ↗
24. 10.1016/j.nantod.2022.10147710.1016/j.nantod.2022.101477 ↗
25. 10.1002/adfm.20220822010.1002/adfm.202208220 ↗
26. 10.1016/j.nanoen.2023.10851010.1016/j.nanoen.2023.108510 ↗
27. 10.1016/j.biomaterials.2023.12203110.1016/j.biomaterials.2023.122031 ↗
28. 10.1038/nchembio.141610.1038/nchembio.1416 ↗
29. 10.1016/j.biomaterials.2021.12111010.1016/j.biomaterials.2021.121110 ↗
30. 10.1016/j.biomaterials.2022.12176210.1016/j.biomaterials.2022.121762 ↗
31. 10.1002/adma.20240719910.1002/adma.202407199 ↗
32. 10.1038/s41467-023-40954-y10.1038/s41467-023-40954-y ↗
33. 10.1007/s40820-022-00894-610.1007/s40820-022-00894-6 ↗
34. 10.1002/adhm.20220242410.1002/adhm.202202424 ↗
35. 10.1002/adfm.20241626510.1002/adfm.202416265 ↗
36. 10.1002/smll.20240474110.1002/smll.202404741 ↗
37. 10.1126/sciadv.adm956110.1126/sciadv.adm9561 ↗
38. 10.1126/sciadv.adl047910.1126/sciadv.adl0479 ↗
39. 10.1021/acsnano.4c0055010.1021/acsnano.4c00550 ↗
40. 10.1038/s43018-024-00760-x10.1038/s43018-024-00760-x ↗
41. 10.1038/s41423-023-00990-610.1038/s41423-023-00990-6 ↗
42. 10.1038/s41571-023-00789-410.1038/s41571-023-00789-4 ↗
43. 10.1016/j.immuni.2023.08.01410.1016/j.immuni.2023.08.014 ↗
44. 10.1038/nri163210.1038/nri1632 ↗